Apomorphine is a bimodal modulator of TRPA1 channels

Molecular Pharmacology

Volumn 83, Issue 2, 2013, Pages 542-551

  Schulze, Anja ^a   Oehler, Beatrice ^a   Urban, Nicole ^a   Schaefer, Michael ^a   Hill, Kerstin ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

APOMORPHINE; CALCIUM; TRANSIENT RECEPTOR POTENTIAL CHANNEL 1; TRANSIENT RECEPTOR POTENTIAL CHANNEL 2; TRANSIENT RECEPTOR POTENTIAL CHANNEL 3; TRANSIENT RECEPTOR POTENTIAL CHANNEL 4; TRANSIENT RECEPTOR POTENTIAL CHANNEL A1; TRANSIENT RECEPTOR POTENTIAL CHANNEL M2; TRANSIENT RECEPTOR POTENTIAL CHANNEL M3; TRANSIENT RECEPTOR POTENTIAL CHANNEL M8;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CELL POPULATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; ELECTRIC CURRENT; ENTEROCHROMAFFIN CELL; HETEROLOGOUS EXPRESSION; HUMAN; HUMAN CELL; NONHUMAN; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SPINAL GANGLION;

ANIMALS; APOMORPHINE; CALCIUM; CELL LINE; FEMALE; GANGLIA, SPINAL; HEK293 CELLS; HUMANS; MALE; NEURONS; RATS; RATS, WISTAR; SEROTONIN; TRANSIENT RECEPTOR POTENTIAL CHANNELS;

EID: 84872714153     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.112.081976     Document Type: Article

References (42)

1. Andersson DA, Gentry C, Moss S, and Bevan S (2008) Transient receptor potential A1 is a sensory receptor for multiple products of oxidative stress. J Neurosci 28: 2485-2494.
2. Andrews PL, Davis CJ, Bingham S, Davidson HI, Hawthorn J, and Maskell L (1990) The abdominal visceral innervation and the emetic reflex: pathways, pharmacology, and plasticity. Can J Physiol Pharmacol 68:325-345.
3. Atoyan R, Shander D, and Botchkareva NV (2009) Non-neuronal expression of transient receptor potential type A1 (TRPA1) in human skin. J Invest Dermatol 129:2312-2315.
4. Axelsson P, Thörn SE, Lövqvist A, Wattwil L, and Wattwil M (2006) Betamethasone does not prevent nausea and vomiting induced by the dopamine-agonist apomor-phine. Can J Anaesth 53:370-374.
5. Bandell M, Story GM, Hwang SW, Viswanath V, Eid SR, Petrus MJ, Earley TJ, and Patapoutian A (2004) Noxious cold ion channel TRPA1 is activated by pungent compounds and bradykinin. Neuron 41:849-857.
6. Banke TG, Chaplan SR, and Wickenden AD (2010) Dynamic changes in the TRPA1 selectivity filter lead to progressive but reversible pore dilation. Am J Physiol Cell Physiol 298:C1457-C1468.
7. Bautista DM, Jordt SE, Nikai T, Tsuruda PR, Read AJ, Poblete J, Yamoah EN, Basbaum AI, and Julius D (2006) TRPA1 mediates the inflammatory actions of environmental irritants and proalgesic agents. Cell 124:1269-1282.
8. Bautista DM, Movahed P, Hinman A, Axelsson HE, Sterner O, Högestätt ED, Julius D, Jordt SE, and Zygmunt PM (2005) Pungent products from garlic activate the sensory ion channel TRPA1. Proc Natl Acad Sci USA 102:12248-12252.
9. Chen J, Kim D, Bianchi BR, Cavanaugh EJ, Faltynek CR, Kym PR, and Reilly RM (2009) Pore dilation occurs in TRPA1 but not in TRPM8 channels. Mol Pain 5:3.
10. Doihara H, Nozawa K, Kawabata-Shoda E, Kojima R, Yokoyama T, and Ito H (2009a) Molecular cloning and characterization of dog TRPA1 and AITC stimulate the gastrointestinal motility through TRPA1 in conscious dogs. Eur J Pharmacol 617: 124-129.
11. Doihara H, Nozawa K, Kawabata-Shoda E, Kojima R, Yokoyama T, and Ito H (2009b) TRPA1 agonists delay gastric emptying in rats through serotonergic pathways. Naunyn Schmiedebergs Arch Pharmacol 380:353-357.
12. Doihara H, Nozawa K, Kojima R, Kawabata-Shoda E, Yokoyama T, and Ito H (2009c) QGP-1 cells release 5-HT via TRPA1 activation; a model of human enterochro-maffin cells. Mol Cell Biochem 331:239-245.
13. Dula E, Bukofzer S, Perdok R, and George M; Apomorphine SL Study Group (2001) Double-blind, crossover comparison of 3 mg apomorphine SL with placebo and with 4 mg apomorphine SL in male erectile dysfunction. Eur Urol 39:558-563, discussion 564.
14. El-Bachá RS, Netter P, and Minn A (1999) Mechanisms of apomorphine cytoxicity towards rat glioma C6 cells: protection by bovine serum albumin and formation of apomorphine-protein conjugates. Neurosci Lett 263:25-28.
15. Frühwald J, Camacho Londoño J, Dembla S, Mannebach S, Lis A, Drews A, Wissenbach U, Oberwinkler J, and Philipp SE (2012) Alternative splicing of a protein domain indispensable for function of transient receptor potential melastatin 3 (TRPM3) ion channels. J Biol Chem 287:36663-36672.
16. Hesketh PJ (2008) Chemotherapy-induced nausea and vomiting. N Engl J Med 358: 2482-2494.
17. Hill K and Schaefer M (2007) TRPA1 is differentially modulated by the amphipathic molecules trinitrophenol and chlorpromazine. J Biol Chem 282:7145-7153.
18. Himeno E, Ohyagi Y, Ma L, Nakamura N, Miyoshi K, Sakae N, Motomura K, Soejima N, Yamasaki R, and Hashimoto T et al. (2011) Apomorphine treatment in Alzheimer mice promoting amyloid-β degradation. Ann Neurol 69:248-256.
19. Hinman A, Chuang HH, Bautista DM, and Julius D (2006) TRP channel activation by reversible covalent modification. Proc Natl Acad Sci USA 103:19564-19568.
20. Holzer P (2011a) Transient receptor potential (TRP) channels as drug targets for diseases of the digestive system. Pharmacol Ther 131:142-170.
21. Holzer P (2011b) TRP channels in the digestive system. Curr Pharm Biotechnol 12: 24-34.
22. Karashima Y, Damann N, Prenen J, Talavera K, Segal A, Voets T, and Nilius B (2007) Bimodal Action of Menthol on the Transient Receptor Potential Channel TRPA1. J Neurosci 27:9874-9884.
23. Karashima Y, Talavera K, Everaerts W, Janssens A, Kwan KY, Vennekens R, Nilius B, and Voets T (2009) TRPA1 acts as a cold sensor in vitro and in vivo. Proc Natl Acad Sci USA 106:1273-1278.
24. Kwan KY, Allchorne AJ, Vollrath MA, Christensen AP, Zhang DS, Woolf CJ, and Corey DP (2006) TRPA1 contributes to cold, mechanical, and chemical noci-ception but is not essential for hair-cell transduction. Neuron 50:277-289.
25. Lefebvre RA, Willems JL, and Bogaert MG (1981) Gastric relaxation and vomiting by apomorphine, morphine and fentanyl in the conscious dog. Eur J Pharmacol 69: 139-145.
26. Leffler A, Lattrell A, Kronewald S, Niedermirtl F, and Nau C (2011) Activation of TRPA1 by membrane permeable local anesthetics. Mol Pain 7:62.
27. Lenz JC, Reusch HP, Albrecht N, Schultz G, and Schaefer M (2002) Ca2+-controlled competitive diacylglycerol binding of protein kinase C isoenzymes in living cells. J Cell Biol 159:291-302.
28. Macpherson LJ, Dubin AE, Evans MJ, Marr F, Schultz PG, Cravatt BF, and Patapoutian A (2007) Noxious compounds activate TRPA1 ion channels through covalent modification of cysteines. Nature 445:541-545.
29. McNamara CR, Mandel-Brehm J, Bautista DM, Siemens J, Deranian KL, Zhao M, Hayward NJ, Chong JA, Julius D, and Moran MM et al. (2007) TRPA1 mediates formalin-induced pain. Proc Natl Acad Sci USA 104:13525-13530.
30. Moreira JC, Dal-Pizzol F, Bonatto F, da Silva EG, Flores DG, Picada JN, Roesler R, and Henriques JA (2003) Oxidative damage in brains of mice treated with apo-morphine and its oxidized derivative. Brain Res 992:246-251.
31. Nassini R, Pedretti P, Moretto N, Fusi C, Carnini C, Facchinetti F, Viscomi AR, Pisano AR, Stokesberry S, and Brunmark C et al. (2012) Transient receptor potential ankyrin 1 channel localized to non-neuronal airway cells promotes non-neurogenic inflammation. PLoS ONE 7:e42454.
32. Nörenberg W, Sobottka H, Hempel C, Plötz T, Fischer W, Schmalzing G, and Schaefer M (2012) Positive allosteric modulation by ivermectin of human but not murine P2X7 receptors. Br J Pharmacol 167:48-66.
33. Nozawa K, Kawabata-Shoda E, Doihara H, Kojima R, Okada H, Mochizuki S, Sano Y, Inamura K, Matsushime H, and Koizumi T et al. (2009) TRPA1 regulates gastrointestinal motility through serotonin release from enterochromaffin cells. Proc Natl Acad Sci USA 106:3408-3413.
34. Oehler B, Scholze A, Schaefer M, and Hill K (2012) TRPA1 is functionally expressed in melanoma cells but is not critical for impaired proliferation caused by allyl iso-thiocyanate or cinnamaldehyde. Naunyn Schmiedebergs Arch Pharmacol 385:555-563.
35. Pelissier T, Laurido C, Hernandez A, Constandil L, and Eschalier A (2006) Biphasic effect of apomorphine on rat nociception and effect of dopamine D2 receptor antagonists. Eur J Pharmacol 546:40-47.
36. Penuelas A, Tashima K, Tsuchiya S, Matsumoto K, Nakamura T, Horie S, and Yano S (2007) Contractile effect of TRPA1 receptor agonists in the isolated mouse intestine. Eur J Pharmacol 576:143-150.
37. Purhonen AK, Louhivuori LM, Kiehne K, Kerman KE, and Herzig KH (2008) TRPA1 channel activation induces cholecystokinin release via extracellular calcium. FEBS Lett 582:229-232.
38. Stokes A, Wakano C, Koblan-Huberson M, Adra CN, Fleig A, and Turner H (2006) TRPA1 is a substrate for de-ubiquitination by the tumor suppressor CYLD. Cell Signal 18:1584-1594.
39. Subramony JA (2006) Apomorphine in dopaminergic therapy. Mol Pharm 3:380-385.
40. Urban N, Hill K, Wang L, Kuebler WM, and Schaefer M (2012) Novel pharmacological TRPC inhibitors block hypoxia-induced vasoconstriction. Cell Calcium 51:194-206.
41. Vilceanu D and Stucky CL (2010) TRPA1 mediates mechanical currents in the plasma membrane of mouse sensory neurons. PLoS ONE 5:e12177.
42. Youssef AF, Fort FL, Ronsen B, Schroeder R, Williams K, and Auletta C (1999) Evaluation of apomorphine HCl effects on reproductive endpoints: studies in male rats and dogs. Toxicol Sci 51:273-279.